Home / NCI OA Special Notice of Subcontract Opportunity at the… / Document

SAM Special Notice - Sources Sought

Updated

A Word document (130 KB) attached to NCI OA Special Notice of Subcontract Opportunity at the Frederick National Laboratory for Cancer Research”, from the National Institutes of Health. Due Nov 20, 2026, 5:00 PM (UTC-5).

File name: SAM Special Notice - Sources Sought S27-106.docx

Download the full documentSee the bid

The full file is for paid members, or buy this bid alone.

Preview

Required Notice Details for Posting Subcontracting Opportunities to SAM.gov The following informational items are needed for posting notices to SAM.gov: Notice ID: S27-106

Sources Sought Notice in support of the National Institute of Allergy and Infectious Diseases (NIAID), to provide support for clinical research infrastructure and operations relating to emerging/re-emerging infectious diseases in the Democratic Republic of the Congo (DRC).

Title: “NCI OA Special Notice of Subcontract Opportunity at the Frederick National Laboratory for Cancer Research”

NAICS: Primary: 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Response Dates:

Anticipated solicitation issuance date is expected to occur prior to February 2027 An estimated proposal due date is anticipated within four (4) weeks after issuance of solicitation. Anticipated Award of one (1) IDIQ with four (4) Task Orders is anticipated be awarded August 31, 2027.

Description: National Institutes of Health, National Cancer Institute, Frederick National Laboratory for Cancer Research Opportunities-Special Notice:

This Special Notice is not a formal Invitation for Bid (IFB), Request for Proposal (RFP), Request for Quotation (RFQ) nor any type of Solicitation for offers. In accordance with FAR 15.201(d), this Special Notice is intended FOR INFORMATIONAL PURPOSES ONLY in order to publicize the requirements of the Frederick National Laboratory for Cancer Research (FNLCR). The FNLCR is a Government-Owned Contractor-Operated Federally Funded Research and Development Center (FFRDC) located at Fort Detrick, Maryland. The FNLCR partners with university, Government, and corporate scientists to speed the translation of laboratory research into new diagnostic tests and treatments for cancer and AIDS. FNLCR is a multi-program laboratory currently operated by Leidos Biomedical Research, Inc. (Leidos Biomed) for the National Cancer Institute (NCI) under Prime Contract No. 75N91019D00024 & HHSN261201500003I, which provides Operations and Technical Support (OTS) for the FNLCR. The Government assumes no liability for reimbursement for any effort or associated costs to respond, nor for any information provided as a result of this Special Notice as no information is being requested. Please be advised that any submissions provided, despite that no information is requested, become Government property and will not be returned, nor will there be any ensuing discussions or debriefings.

The beginning of the document. Download the full file to read on.